Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cancer Proteomics

Emmanuel Barillot's Biography



Emmanuel Barillot, Bioinformatics and IT Director, Institut Curie

Emmanuel Barillot earned an engineering degree from Ecole Centrale de Paris in 1988 and a PhD in Bioinformatics in 1992 at Généthon/CEPH in Paris where he headed the bioinformatics group up to the construction of the first physical map of the human genome in 1995. Then he created a research group in genomic data integration at Infobiogen, the French national bioinformatics center. In early 2000 he joined the National Agricultural Research Institute (INRA) to create a unit for plant bioinformatics, focusing on heterogeneous data integration. In late 2002 he joined institut Curie to create a bioinformatics core facility and a research group in computational systems biology of cancer. Since 2008 he is heading the Department of Epidemiology, Biostatistics, Bioinformatics and Computational Systems Biology of Cancer (U900), a joint Institut Curie and INSERM research department, in partnership with Mines ParisTech.
His research focus on statistical analysis of large scale biological data, integration of heterogeneous biological data and biological network modelling in the context of cancer.

Emmanuel Barillot Image

Modeling Signalling Networks Involved in Carcinogenesis

Wednesday, 17 October 2012 at 15:45

Add to Calendar ▼2012-10-17 15:45:002012-10-17 16:45:00Europe/LondonModeling Signalling Networks Involved in CarcinogenesisSELECTBIOenquiries@selectbiosciences.com

The subject of the presentation will deal with several approaches we have implemented for investigating how a biological network can control cellular processes in cancer, and give rise to tumorigenesis, tumor progression, or therapeutic response or resistance. In particular we are interested in predicting the fate of cells or tumors upon different perturbations (either genetic, chemical or other): death, proliferation, invasion, metastasis...


Add to Calendar ▼2012-10-16 00:00:002012-10-17 00:00:00Europe/LondonCancer ProteomicsSELECTBIOenquiries@selectbiosciences.com